from TheAge
"
10:20am: The main loser among the top 200 this morning is CSL, which is down about 5 per cent after an Alzheimer's therapy by competitor Baxter failed in late stage trial.
This is seen as a blow for CSL as both the Australian company and Baxter stood to benefit from the potential use of immunoglobulin treatments in Alzheimer's patients.
"
Read more: http://www.theage.com.au/business/markets-live/markets-live-strong-start-for-stocks-20130508-2j6lc.html#ixzz2SekCqnAq
price drop, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$305.54 |
Change
-4.850(1.56%) |
Mkt cap ! $147.6B | |||
| Open | High | Low | Value | Volume |
| $307.68 | $309.50 | $305.54 | $259.6M | 847.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 640 | $305.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $306.30 | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |